1. >
  2. Investors
  3. >
  4. Regulated Information
  5. >
  6. Press Releases – Reg...


Found 308 Results
Page 3 of 31

Onxeo appoints Julien Miara as new interim CEO

Paris (France), January 3rd, 2022 – 6:00 pm CET – Onxeo S.A. (Euronext Growth Paris: ALONX, First North Copenhagen: ONXEO), (“Onxeo” or “the Company”), […]


New preclinical data confirm the ability of AsiDNA™ to tackle the drug-tolerant persister cells and prevent tumor resistance in several combination treatments

These pioneering data were highlighted at the EACR-AstraZeneca Virtual Conference during two dedicated sessions   Paris (France), December 8, 2021 […]


Onxeo Continues to Strengthen its Board of Directors

Bryan Giraudo, COO & CFO of U.S. biopharmaceutical company Gossamer Bio, joins the Company’s Board as independent member   Paris […]


Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare Sector

Dr Robert L. Coleman, Chief Scientific Officer of US Oncology Network and Dr Jacques Mallet, former SVP Portfolio Analytics/Corporate Strategy […]


Onxeo Reports its 2021 Half-Yearly Financial Results and Provides an Update on its Activities

Cash position of €24.5 million as of June 30, 2021, providing financial visibility until the end of 2022 and enabling […]


Onxeo Announces the Appointment of Dr. Shefali Agarwal as the Company’s Chairwoman of the Board

Danièle Guyot-Caparros, outgoing Chairwoman, remains an independent member of the Board of Directors and Chair of the Audit Committee   […]


Onxeo: Report on the Combined General Meeting of June 10, 2021

All resolutions voted in accordance with Board of Directors’ recommendations Shefali Agarwal, MD, a clinical development expert in oncology, is […]


Onxeo Receives Notice of Allowance for a New Patent Broadening the Protection of AsiDNA™ in combination with a PARP Inhibitor in the United States

This new patent protects both AsiDNA™ in combination with a PARP inhibitor and the use of the combination for the […]


Onxeo Announces Formation of Scientific Advisory Committee of Leading Independent Experts

This newly formed committee of international specialists will advise on the scientific and clinical aspects related to the development of […]


Onxeo’s Combined General Meeting on June 10, 2021 in camera: availability of preparatory documents and live webcast login information

Paris (France), May 21, 2021 – 5:45 p.m. CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO – FR0010095596), (“Onxeo”, […]


Page 3 of 31